SCHEMBL4988191

SCHEMBL4988191

C[C@H](O)[C@](O)(C(=O)O)[C@H](O)C=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2636316 1.00 TP53 (0.32) TP53ALDH1A1TSHR
SCHEMBL28378214 1.00 TP53 (0.32) TP53ALDH1A1TSHR
SCHEMBL6057041 0.75 ALDH1A1 (0.38) TP53ALDH1A1TSHR
SCHEMBL29067218 0.71
SCHEMBL29449990 0.67
SCHEMBL28564754 0.67
SCHEMBL5711892 0.66 ALDH1A1 (0.44) TP53ALDH1A1TSHR
SCHEMBL10833192 0.65 CHRM1 (0.38) TSHR
SCHEMBL324849 0.64
SCHEMBL27874503 0.64 ALDH1A1 (0.42) TP53ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4691450-A2 PERSONAL CLEANSING COMPOSITIONS The Procter & Gamble Company (US) 2026-02-11 EP disclosed
EP-3319457-B1 METHOD FOR MODIFYING THE FEED INTAKE PATERN NUTRITION SCIENCES NV (BE) 2025-11-19 EP disclosed
US-20250332082-A1 PERSONAL CLEANSING COMPOSITIONS, METHODS AND USES PROCTER & GAMBLE (US) 2025-10-30 US disclosed
US-20250319010-A1 PERSONAL CLEANSING COMPOSITIONS, METHODS AND USES PROCTER & GAMBLE (US) 2025-10-16 US disclosed
US-12390407-B2 Personal cleansing compositions, methods and uses THE PROCTER & GAMBLE COMPANY (US) 2025-08-19 US disclosed
EP-4578940-A2 USES OF BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISM Société des Produits Nestlé S.A. (CH) 2025-07-02 EP disclosed
CN-117837746-A Food and/or feed composition for preventing and treating inflammatory diseases 帝斯曼知识产权资产管理有限公司 2024-04-09 CN disclosed
CN-112512490-B Personal cleansing compositions 宝洁公司 2023-07-28 CN disclosed
CN-112469387-B Personal cleansing compositions, methods and uses 宝洁公司 2023-07-14 CN disclosed
US-11638683-B2 Personal cleansing compositions THE PROCTER & GAMBLE COMPANY (US) 2023-05-02 US disclosed
US-6994966-B2 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof GLYCOMINDS LTD. (IL) 2006-02-07 US disclosed
US-20050277154-A1 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof GLYCOMINDS LTD. 2005-12-15 US disclosed
US-6972172-B2 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof GLYCOMINDS LTD. (IL) 2005-12-06 US disclosed
EP-0939772-B1 PLANT RHAMNOGALACTURONAN II COMPLEXATION OF HEAVY METAL CATIONS UNIV GEORGIA RES FOUND (US) 2001-10-17 EP disclosed
US-6103506-A EXTRACT WITH HYDROLASE ACTIVITY; FOR DESTROYING POLYSACCHARIDE CONSTITUENTS OF THE CELL WALLS INSTITUTE NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 2000-08-15 US disclosed
EP-0939772-A1 PLANT RHAMNOGALACTURONAN II COMPLEXATION OF HEAVY METAL CATIONS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1999-09-08 EP disclosed
US-5877164-A COMPLEXES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1999-03-02 US disclosed
WO-1998022511-A1 PLANT RHAMNOGALACTURONAN II COMPLEXATION OF HEAVY METAL CATIONS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) 1998-05-28 WO disclosed
EP-0827533-A2 ENZYME AND MICROORGANISM DEGRADING RHAMNOGALACTURONANE II INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 1998-03-11 EP disclosed
WO-1996037604-A2 ENZYME AND MICROORGANISM DEGRADING RHAMNOGALACTURONANE II INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 1996-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319010-A1 PERSONAL CLEANSING COMPOSITIONS, METHODS AND USES SGMS1, SGMS2, PHOSPHO1 TP53 2888/4885ALDH1A1 3806/4885TSHR 3885/4885
US-12390407-B2 Personal cleansing compositions, methods and uses SGMS1, SGMS2, PHOSPHO1 TP53 2888/4885ALDH1A1 3806/4885TSHR 3885/4885
US-20250332082-A1 PERSONAL CLEANSING COMPOSITIONS, METHODS AND USES SGMS1, SGMS2, PHOSPHO1 TP53 2888/4885ALDH1A1 3806/4885TSHR 3885/4885
US-11638683-B2 Personal cleansing compositions PHOSPHO1, SGMS1, SGMS2 TP53 3540/4885ALDH1A1 4498/4885TSHR 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.